Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Supracondylar Post-Operative Pain Study
- Conditions
- Interventions
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 90
- Registration Number
- NCT03759028
- Locations
- 🇺🇸
Orthopaedic Institute for Children, Los Angeles, California, United States
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Göteborg University
- Target Recruit Count
- 220
- Registration Number
- NCT03756961
- Locations
- 🇸🇪
Lindesberg Hospital, Lindesberg, Region Örebro, Sweden
🇸🇪Sahlgrenska University hospital/ Östra hopsital, Gothenburg, VG, Sweden
Efficacy of Oxycodone-propofol Combination Compared With a Fentanyl-propofol Combination on Conscious Sedation Effect and Early Cognitive Function During Therapeutic Endoscopic Retrograde Cholangio-pancreatography
- Conditions
- Interventions
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2018-11-28
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03755609
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, Shanghai, China
Oxycodone and Sufentanil for Analgesia in Hip Surgery
- Conditions
- Interventions
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 570
- Registration Number
- NCT03685188
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 26
- Registration Number
- NCT03679949
- Locations
- 🇺🇸
New York State Psychiatric Institute, New York, New York, United States
Non-opioids for Analgesia After Adenotonsillectomy in Children
- Conditions
- Interventions
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- David Chi, MD
- Target Recruit Count
- 268
- Registration Number
- NCT03618823
- Locations
- 🇺🇸
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
- Conditions
- Interventions
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2019-03-18
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT03616639
- Locations
- 🇳🇱
Envida - Koepelhof, Maastricht, Limburg, Netherlands
🇳🇱Envida - Grubbeveld, Maastricht, Limburg, Netherlands
🇳🇱Envida - La Valence, Maastricht, Limburg, Netherlands
Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients
- Conditions
- Interventions
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- Concentric Analgesics
- Target Recruit Count
- 147
- Registration Number
- NCT03599089
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸Chesapeake Research Group, Pasadena, Maryland, United States
🇺🇸HD Research Corp, Houston, Texas, United States
ESP vs ESP With PECS
- First Posted Date
- 2018-07-19
- Last Posted Date
- 2019-03-01
- Lead Sponsor
- Medical University of Lublin
- Target Recruit Count
- 33
- Registration Number
- NCT03592485
- Locations
- 🇵🇱
Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszów, Poland, Rzeszów, Poland
Ambulatory Gynecologic Surgery: Finding the Optimal Opioid Prescription
- Conditions
- Interventions
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2021-08-13
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT03588910
- Locations
- 🇺🇸
Montefiore Medical Center, Bronx, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.